<!DOCTYPE html>
<html>
<head>
    <title>全文阅读--XML全文阅读--中国知网</title>
    <link rel="icon" href="/kxreader/favicon.ico" />
    <link rel="shortcut Icon" href="/kxreader/favicon.ico" />
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <meta name="keywords" content="文献 XML KBASE CNKI 中国知网" />
    <meta name="description" content="XML文献检索" />
    <link href="/kxreader/Content/css/detail?v=NOOK-mvTMnxl11s6oPYV0boPXN3iP4N7Rc-A56nk4KI1" rel="stylesheet"/>

    <script type="text/javascript">
        var APPPATH = '/kxreader';
    </script>
</head>

<body>
    
<script type="text/javascript" src="//login.cnki.net/TopLogin/api/loginapi/get?type=top&amp;localCSS=&amp;returnurl=%2f%2fkns.cnki.net%2fKXReader%2fDetail%3fTIMESTAMP%3d637141665604951250%26DBCODE%3dCJFD%26TABLEName%3dCJFDLAST2019%26FileName%3dXXGK201904023%26RESULT%3d1%26SIGN%3ddfmdqsT7P1b4Vu8S629M%252bPq6aLw%253d"></script>

<div id="headerBox" class="header">
    <div class="topbar">
        <div class="textalign">
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904023&amp;align=md">
                <i class="icon-cen active" title="居中对齐"></i>
            </a>
            <a href="/kxreader/Detail?dbcode=CJFD&amp;filename=XXGK201904023&amp;align=lt">
                <i class="icon-left " title="左对齐"></i>
            </a>
        </div>
        <h6 class="free-tip"><i class="icon"></i>HTML阅读开放试用阶段，欢迎体验！</h6>
    </div>
</div>

    



<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904023&amp;v=MDA3Mjc0SDlqTXE0OUhaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3S1BUWE1aYkc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>

    <div class="main">

        

    <div class="sidebar-a">
        <!--sidebar start-->
        <div class="sidenav">
            <div class="arrow"><span></span></div>
            <!--sidebar_list start-->
            <dl class="sidenav-list">
                    <dt class="tit">目录结构</dt>
                            <dd class="guide">
                                    <p><a href="#40" data-title="&lt;b&gt;1 资料与方法&lt;/b&gt; "><b>1 资料与方法</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#41" data-title="1.1 一般资料">1.1 一般资料</a></li>
                                                <li><a href="#43" data-title="1.2 治疗方法">1.2 治疗方法</a></li>
                                                <li><a href="#45" data-title="1.3 评估标准">1.3 评估标准</a></li>
                                                <li><a href="#47" data-title="1.4 统计学方法">1.4 统计学方法</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#50" data-title="&lt;b&gt;2 结 果&lt;/b&gt; "><b>2 结 果</b></a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#51" data-title="2.1 两组TIMI血流分级比较">2.1 两组TIMI血流分级比较</a></li>
                                                <li><a href="#54" data-title="2.2 两组LVEF及LVEDd比较">2.2 两组LVEF及LVEDd比较</a></li>
                                                <li><a href="#56" data-title="2.3 两组sST2及PTX3水平比较">2.3 两组sST2及PTX3水平比较</a></li>
                                                <li><a href="#58" data-title="2.4 两组MACE发生率比较">2.4 两组MACE发生率比较</a></li>
                                    </ul>
                            </dd>
                            <dd class="guide">
                                    <p><a href="#65" data-title="&lt;b&gt;3 讨 论&lt;/b&gt; "><b>3 讨 论</b></a><i></i></p>
                                                            </dd>
                            <dd class="guide">
                                    <p><a href="#" data-title="文内图表 ">文内图表</a><i></i></p>
                                                                    <ul class="contentbox">
                                                <li><a href="#53" data-title="&lt;b&gt;表&lt;/b&gt;1 &lt;b&gt;两组&lt;/b&gt;PCI&lt;b&gt;前后&lt;/b&gt;TIMI&lt;b&gt;血流分级&lt;/b&gt; (n=73) "><b>表</b>1 <b>两组</b>PCI<b>前后</b>TIMI<b>血流分级</b> (n=73) </a></li>
                                                <li><a href="#60" data-title="表2 各组LVEF及LVEDd比较（&lt;image id=&quot;86&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904023_08600.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=73) ">表2 各组LVEF及LVEDd比较（<image id="86" type="formula" href="images/XXGK201904023_08600.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=73) </a></li>
                                                <li><a href="#62" data-title="表3 两组sST2及PTX3表达水平比较（&lt;image id=&quot;87&quot; type=&quot;formula&quot; href=&quot;images/XXGK201904023_08700.jpg&quot; display=&quot;inline&quot; placement=&quot;inline&quot;&gt;&lt;alt&gt;&lt;/alt&gt;&lt;/image&gt;&#177;s，n=73) ">表3 两组sST2及PTX3表达水平比较（<image id="87" type="formula" href="images/XXGK201904023_08700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=73) </a></li>
                                                <li><a href="#64" data-title="&lt;b&gt;表&lt;/b&gt;4 &lt;b&gt;两组患者主要心血管不良事件发生率比较&lt;/b&gt; (n=73) "><b>表</b>4 <b>两组患者主要心血管不良事件发生率比较</b> (n=73) </a></li>
                                    </ul>
                            </dd>
                                    <dd class="guide">
                                        <h6>
                                            <p><a href="#a_bibliography">参考文献</a> </p>
                                        </h6>
                                    </dd>

            </dl>
        </div>
        <!--sidebar end-->
        &nbsp;
        <!--此处有一空格符 勿删-->
    </div>

                <div class="sidebar-b three-collumn" style="width:0;">
            <div class="refer" style="width: 0;">
                <div class="arrow off" title="参考文献"><span></span></div>
                <div class="js-scrollbox" >
                    
                    <div class="subbox active">
                        <h4>
                            <span class="tit">参考文献</span>
                            <a class="close" href="javascript:void(0)">x</a>
                        </h4>
                        <div class="side-scroller">
                            <ul class="refer-list">
                                <li id="5">


                                    <a id="bibliography_1" title="Boukhris M, Bousselmi R, Tomasello S D, et al.Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention.[J].J Saudi Heart Assoc, 2015, 27 (3) :192-200." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14121200074416&amp;v=MDQ5NzRQTnJZOUZaT3dMQ0gwL29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1RheGM9TmlmT2ZiSzhIOQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[1]</b>
                                        Boukhris M, Bousselmi R, Tomasello S D, et al.Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention.[J].J Saudi Heart Assoc, 2015, 27 (3) :192-200.
                                    </a>
                                </li>
                                <li id="7">


                                    <a id="bibliography_2" title="Dastidar AG, Rodrigucs J, Baritussio A, et al.Reply:Complete ReVascization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI:Is It Really What We Should Be Doing?[J].Journal of the American College of Cardiology, 2015, 66 (3) :331-332." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESB7182A561FFEBC0C886271E837502DEA&amp;v=MDE5NTcyVWI0amwvVDM2WHBCRXlmTEtXTWMvdUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMcTR3YTA9TmlmT2ZjRy9IOW5PM29wRFpaMTVlUTVLeg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[2]</b>
                                        Dastidar AG, Rodrigucs J, Baritussio A, et al.Reply:Complete ReVascization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI:Is It Really What We Should Be Doing?[J].Journal of the American College of Cardiology, 2015, 66 (3) :331-332.
                                    </a>
                                </li>
                                <li id="9">


                                    <a id="bibliography_3" title=" Fu X, Wang Z, Wang Y, et al.Safety and efficacy of early application of tirofiban in STEMI patients undergoing primary percutaneous coronary intervention[J].Heart, 2011, 97 (Suppl 3) :A153-A153." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Safety and efficacy of early application of tirofiban in STEMI patients undergoing primary percutaneous coronary intervention">
                                        <b>[3]</b>
                                         Fu X, Wang Z, Wang Y, et al.Safety and efficacy of early application of tirofiban in STEMI patients undergoing primary percutaneous coronary intervention[J].Heart, 2011, 97 (Suppl 3) :A153-A153.
                                    </a>
                                </li>
                                <li id="11">


                                    <a id="bibliography_4" title="胡振, 张新超.可溶性人基质裂解素2在评估心力衰竭病情和预后中的作用[J].中国全科医学, 2016, 19 (27) :3375-3379." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYX201627028&amp;v=MTg0OTdJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdOTkNiU2RyRzRIOWZPcUk5SGI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[4]</b>
                                        胡振, 张新超.可溶性人基质裂解素2在评估心力衰竭病情和预后中的作用[J].中国全科医学, 2016, 19 (27) :3375-3379.
                                    </a>
                                </li>
                                <li id="13">


                                    <a id="bibliography_5" title="侯维娜, 金凤表, 孙宏超, 等.血清Syndecan-4、PTX-3、BNP水平检测在诊断慢性心力衰竭的临床价值[J].实用医学杂志, 2016, 32 (22) :3709-3712." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201622022&amp;v=MTY2NjNVUjdxZlp1Wm1GeWpuVkw3Tk5qVFNkTEc0SDlmT3JZOUhab1FLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckM=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[5]</b>
                                        侯维娜, 金凤表, 孙宏超, 等.血清Syndecan-4、PTX-3、BNP水平检测在诊断慢性心力衰竭的临床价值[J].实用医学杂志, 2016, 32 (22) :3709-3712.
                                    </a>
                                </li>
                                <li id="15">


                                    <a id="bibliography_6" title="中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-393." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX201505003&amp;v=MTIxMDBGckNVUjdxZlp1Wm1GeWpuVkw3TlB5WFRkckc0SDlUTXFvOUZaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[6]</b>
                                        中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-393.
                                    </a>
                                </li>
                                <li id="17">


                                    <a id="bibliography_7" title="程云涛, 杨光霞, 李传方, 等.替罗非班联合大剂量阿托伐他汀对急诊PCI术中冠状动脉血流恢复的影响[J].中国循证心血管医学杂志, 2016, 8 (1) :43-45, 53." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201601014&amp;v=MDAxNTVxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdOTlRmVGRyRzRIOWZNcm85RVlJUUtESDg0dlI0VDZqNTRPM3o=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[7]</b>
                                        程云涛, 杨光霞, 李传方, 等.替罗非班联合大剂量阿托伐他汀对急诊PCI术中冠状动脉血流恢复的影响[J].中国循证心血管医学杂志, 2016, 8 (1) :43-45, 53.
                                    </a>
                                </li>
                                <li id="19">


                                    <a id="bibliography_8" title="Paltaci I, Aydogan A, Akkucuk S, et al.Protective effects of tirofiban hydrochloride, a glycoprotein IIb/IIIa inhibitor, on liver ischemia/reperfusion injury in rats[J].Acta Medica Mediterranea, 2015, 31 (1) :121-126." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Protective effects of tirofiban hydrochloride,a glycoprotein IIb/IIIa inhibitor,on liver ischemia/reperfusion injury in rats">
                                        <b>[8]</b>
                                        Paltaci I, Aydogan A, Akkucuk S, et al.Protective effects of tirofiban hydrochloride, a glycoprotein IIb/IIIa inhibitor, on liver ischemia/reperfusion injury in rats[J].Acta Medica Mediterranea, 2015, 31 (1) :121-126.
                                    </a>
                                </li>
                                <li id="21">


                                    <a id="bibliography_9" title="T&#252;rker Y.Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :956." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI">
                                        <b>[9]</b>
                                        T&#252;rker Y.Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :956.
                                    </a>
                                </li>
                                <li id="23">


                                    <a id="bibliography_10" title="Wang K, Zuo G, Zheng L, et al.Effects of Tirofiban on Platelet Activation and Endothelial Function in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention[J].Cell BioChem Biophy, 2015, 71 (1) :135-142." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD15011600011155&amp;v=MDE4MzdqN0Jhcks5SHRETnFZOUZaT29PRFhrOG9CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1RheGM9Tg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[10]</b>
                                        Wang K, Zuo G, Zheng L, et al.Effects of Tirofiban on Platelet Activation and Endothelial Function in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention[J].Cell BioChem Biophy, 2015, 71 (1) :135-142.
                                    </a>
                                </li>
                                <li id="25">


                                    <a id="bibliography_11" title="陈晖, 余淑华, 刘毓.替罗非班在急性ST段抬高型心肌梗死直接PCI术中的应用[J].中国实用医刊, 2015, 42 (2) :91-92." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=MEDI201502043&amp;v=MjI4MjFIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN05LQ2pQWjdHNEg5VE1yWTlCWjRRS0Q=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[11]</b>
                                        陈晖, 余淑华, 刘毓.替罗非班在急性ST段抬高型心肌梗死直接PCI术中的应用[J].中国实用医刊, 2015, 42 (2) :91-92.
                                    </a>
                                </li>
                                <li id="27">


                                    <a id="bibliography_12" title="Kaymaz C, Keles N, &#213;zdemir N, et al.The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :899-906." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI">
                                        <b>[12]</b>
                                        Kaymaz C, Keles N, &#213;zdemir N, et al.The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :899-906.
                                    </a>
                                </li>
                                <li id="29">


                                    <a id="bibliography_13" title="李宇球, 林玲, 王蓓.射血分数保留的心力衰竭生物标志物的研究进展[J].临床心血管病杂志, 2016, 32 (4) :403-408." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCXB201604021&amp;v=MjkxNTlOS1M3VGJMRzRIOWZNcTQ5SFpZUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[13]</b>
                                        李宇球, 林玲, 王蓓.射血分数保留的心力衰竭生物标志物的研究进展[J].临床心血管病杂志, 2016, 32 (4) :403-408.
                                    </a>
                                </li>
                                <li id="31">


                                    <a id="bibliography_14" title="何蕾, 彭剑, 郑璇, 等.血清可溶性致癌抑制因子2水平与急性ST段抬高型心肌梗死患者近期临床预后的相关性研究[J].中国循环杂志, 2017, 32 (1) :41-45." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGXH201701011&amp;v=MzE4ODY0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDdOUHlyVFpyRzRIOWJNcm85RVpZUUtESDg0dlI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[14]</b>
                                        何蕾, 彭剑, 郑璇, 等.血清可溶性致癌抑制因子2水平与急性ST段抬高型心肌梗死患者近期临床预后的相关性研究[J].中国循环杂志, 2017, 32 (1) :41-45.
                                    </a>
                                </li>
                                <li id="33">


                                    <a id="bibliography_15" title="Yuan X, Xiang Y, Zhu N, et al.Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation[J].Exp Ther Med, 2017, 14 (2) :961-966." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=SJSD&amp;filename=SJSD6EF108C501D94B8E2AA29267D8DEDC5C&amp;v=MDY5MTR4QVpPcDdCWGhMeDJNUm0wNS9RWDNrcTJZOURjZmdOci9zQ09OdkZTaVdXcjdKSUZwbWFCdUhZZk9HUWxmQnJMVTA1dEJoeExxNHdhMD1OaWZZYXJYTmFORE1wLw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[15]</b>
                                        Yuan X, Xiang Y, Zhu N, et al.Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation[J].Exp Ther Med, 2017, 14 (2) :961-966.
                                    </a>
                                </li>
                                <li id="35">


                                    <a id="bibliography_16" title="王江友, 陈涵, 苏晞, 等.可溶性生长刺激表达因子-2对不同类型冠心病患者远期预后的影响[J].中国介入心脏病学杂志, 2016, 24 (4) :195-199." target="_blank"
                                       href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZJXB201604007&amp;v=MDMyOTVuVkw3TlB5ZlRiTEc0SDlmTXE0OUZZNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <b>[16]</b>
                                        王江友, 陈涵, 苏晞, 等.可溶性生长刺激表达因子-2对不同类型冠心病患者远期预后的影响[J].中国介入心脏病学杂志, 2016, 24 (4) :195-199.
                                    </a>
                                </li>
                                <li id="37">


                                    <a id="bibliography_17" title="Yaman M, Arslan U, Beton O, et al.Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio[J].Eur Rev Med Pharmacol Sci, 2016, 20 (5) :912-918." target="_blank"
                                       href="http://scholar.cnki.net/result.aspx?q=Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio">
                                        <b>[17]</b>
                                        Yaman M, Arslan U, Beton O, et al.Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio[J].Eur Rev Med Pharmacol Sci, 2016, 20 (5) :912-918.
                                    </a>
                                </li>
                            </ul>
                            <div style='display: none;' class="zqscroller" >
                                <h4 class="">附加材料</h4>
                                <ul></ul>
                            </div>
                        </div>
                    </div>
                </div>
            </div>
            &nbsp;
            <!--此处有一空格符 勿删-->
        </div>

        
    <div class="content">



        <!--tips start-->
                            <div class="tips">
                    <a href="http://navi.cnki.net/KNavi/JournalDetail?pcode=CJFD&amp;pykm=XXGK" target="_blank">心血管康复医学杂志</a>
                2019,28(04),481-485 DOI:10.3969/j.issn.1008-0074.2019.04.23            </div>
        <!--tips end-->
            <div class="top-title">
                <h1 class="title">
                    <span class="vm"><b>替罗非班辅助</b>PCI<b>对急性</b>ST<b>段抬高型心肌梗死患者血清</b>sST2<b>及</b>PTX-3<b>水平的影响</b></span>
                                    </h1>

            </div>
                        <h2>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%A8%E9%9B%AF%E9%9D%99&amp;code=24764337&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">杨雯静</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E6%9D%8E%E4%B8%BA&amp;code=38602671&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">李为</a>
                                <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=au&amp;skey=%E8%8A%A6%E4%BC%9F&amp;code=38602672&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">芦伟</a>
                </h2>
                    <h2>
                    <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=in&amp;skey=%E7%9A%96%E5%8C%97%E7%85%A4%E7%94%B5%E9%9B%86%E5%9B%A2%E6%80%BB%E5%8C%BB%E9%99%A2%E5%BF%83%E5%86%85%E7%A7%91&amp;code=0219479&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">皖北煤电集团总医院心内科</a>
            </h2>

        
<div class="link">
    <a id="aexport" class="icon icon-output"  onclick="" href="javascript:void(0);"><i></i>导出/参考文献</a>
    
    <span class="shareBoard" onmouseover="$('#sharedet').show();$('#this').addClass('shareBoardCUR')" onmouseout="$('#sharedet').hide();$('#this').removeClass('shareBoardCUR')">
        <a class="icon icon-share" href="#"><i></i>分享<em></em></a>
        <ul class="shareHide" id="sharedet" style="display: none;">
            <li><a title="复制链接" class="copy" onclick="" href="#"><i></i>复制链接</a></li>
            <li><a title="分享到新浪微博" class="xl" onclick="" href="javascript:common.ShareAction('xl');"><i></i>新浪微博</a></li>
            <li>
                <a title="分享到微信" class="wx" onclick="" href="#"><i></i>微信扫一扫</a>
                <div class="qrcode"><img src='' alt='' /></div>
            </li>
        </ul>

    </span>
    
    <a id="RefTrack" title="创建引文跟踪" class="icon icon-track" onclick="" href="javascript:void(0);"> <i></i>创建引文跟踪 </a>
    <a id="ashoucang" title="收藏" class="icon icon-favor" onclick="" href="javascript:void(0);"><i></i>收藏</a>
    <a class="icon icon-print" onclick="window.print();" href="javascript:void(0);"><i></i>打印</a>
    
    <!--版本切换 end-->
</div>
                            <div class="data" id="a_abstract">
                <span class="keys">摘<span style="font-family: 'Times New Roman';">&nbsp;&nbsp;&nbsp;&nbsp;</span>要：</span>
                <p><b>目的</b>:探讨替罗非班辅助PCI对急性ST段抬高型心肌梗死 (STEMI) 患者的临床疗效及对血清可溶性基质裂解素2 (sST2) 及正五聚体蛋白-3 (PTX-3) 水平的影响。<b>方法</b>:2014年～2017年在我院就诊的146例STEMI患者, 患者被随机均分为单纯PCI组及联合治疗组 (替罗非班+PCI术) , 术后两组均接受阿司匹林联合氯吡格雷治疗7d。随访6个月, 观察比较两组术前、术后1个月TIMI血流分级、血清sST2和PTX-3水平, 术前、术后6个月LVEDd, LVEF, 以及随访6个月内的主要不良心血管事件 (MACE) 率。<b>结果</b>:治疗后, 联合治疗组TIMI&lt;3级比例显著低于单纯PCI组 (13.7%比34.2%, <i>P</i>=0.003) 。与单纯PCI组比较, 联合治疗组术后6个月LVEF[ (54.34±6.57) %比 (61.42±7.31) %]显著升高, 而LVEDd[ (49.35±3.13) mm比 (43.54±3.44) mm]、术后1个月血清sST2[ (57.42±8.93) μg/L比 (35.22±8.53) μg/L]及PTX-3 [ (0.64±0.11) μg/L比 (0.43±0.09) μg/L]水平均显著降低 (<i>P</i>均=0.001) ;联合治疗组MACE总发生率显著降低 (24.7%比2.7%, <i>P</i>=0.001) 。<b>结论</b>:替罗非班辅助PCI有利于改善STEMI术后心功能、降低血清sST2及PTX-3水平, 减少MACE发生率, 值得推广。</p>
            </div>
                    <div class="data" id="a_keywords">
                <span class="keys">关键词：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E5%BF%83%E8%82%8C%E6%A2%97%E6%AD%BB&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">心肌梗死;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E8%A1%80%E7%AE%A1%E6%88%90%E5%BD%A2%E6%9C%AF%2C%20%E6%B0%94%E5%9B%8A%2C%20%E5%86%A0%E7%8A%B6%E5%8A%A8%E8%84%89&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">血管成形术, 气囊, 冠状动脉;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%9B%BF%E7%BD%97%E9%9D%9E%E7%8F%AD&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">替罗非班;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=ST%E6%AE%B5%E6%8A%AC%E9%AB%98%E5%9E%8B%E5%8F%AF%E6%BA%B6%E6%80%A7%E5%9F%BA%E8%B4%A8%E8%A3%82%E8%A7%A3%E7%B4%A02&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">ST段抬高型可溶性基质裂解素2;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=%E6%AD%A3%E4%BA%94%E8%81%9A%E4%BD%93%E8%9B%8B%E7%99%BD-3&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">正五聚体蛋白-3;</a>
                </p>
            </div>
        
        <!--brief start-->
        
            <div class="brief">
                    <p>
                                            </p>
                                    <p><b>收稿日期：</b>2018-01-25</p>

            </div>
                    <h1>Influence of tirofiban-assisted PCI on serum sST2 and PTX-3 levels in patients with acute ST-segment elevation myocardial infarction</h1>
                    <h2>
                    <span>YANG Wen-jing</span>
                    <span>LI Wei</span>
                    <span>LU Wei</span>
            </h2>
                    <h2>
                    <span>Department of Cardiology, Wanbei Coal and Electricity Group General Hospital</span>
            </h2>
                            <div class="data" id="a_abstractEN">
                <span class="keys">Abstract：</span>
                <p><b>Objective</b>:To explore therapeutic effect of tirofiban-assisted percutaneous coronary intervention (PCI) on patients with acute ST-segment elevation myocardial infarction (STEMI) and its influence on serum levels of soluble stromelysin 2 (sST2) and pentraxin (PTX) -3. <b>Methods</b>:A total of 146 STEMI patients treated in our hospital from 2014 to 2017 were randomly and equally divided into pure PCI group and combined treatment group (received tirofiban and PCI) , both groups received aspirin and clopidogrel for 7 d after PCI. After treatment, TIMI blood flow grade, serum levels of sST2 and PTX-3, LVEDd and LVEF and incidence of major adverse cardiovascular events (MACE) were observed and compared between two groups. <b>Results</b>:After treatment, percentage of TIMI&lt;grade 3 in combined treatment group was significantly lower than that of pure PCI group (13.7% vs. 34.2%, <i>P</i>=0.003 ) . Compared with pure PCI group, there was significant rise in LVEF [ (54.34±6.57) % vs. (61.42±7.31) %] and significant reductions in LVEDd [ (49.35±3.13) mm vs. (43.54±3.44) mm] after six months, serum levels of sST2[ (57.42±8.93) μg/L vs. (35.22±8.53) μg/L] and PTX-3 [ (0.64±0.11) μg/L vs. (0.43±0.09) μg/L] after one month in combined treatment group, <i>P</i>=0.001 all. During six-month follow-up, total incidence rate of MACE in combined treatment group was significantly lower than that of pure PCI group (2.7% vs. 24.7%, <i>P</i>=0.001) . <b>Conclusion</b>:Tirofiban-assisted PCI is beneficial for improving cardiac function, reducing serum sST2 and PTX-3 levels and incidence rate of MACE in STEMI patients after PCI, which is worth extending. 24</p>
            </div>
                    <div class="data" id="a_keywordsEN">
                <span class="keys">Keyword：</span>
                <p>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Myocardial%20infarction&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Myocardial infarction;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Angioplasty%2C%20Balloon%2C%20Coronary&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Angioplasty, Balloon, Coronary;</a>
                        <a href="/kcms/detail/knetsearch.aspx?dbcode=CJFD&amp;sfield=kw&amp;skey=Tirofiban&amp;code=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" target="_blank">Tirofiban;</a>
                </p>
            </div>
                    <div class="brief">
                
                    <p>
                                            </p>
                                    <p><b>Received：</b> 2018-01-25</p>
                            </div>


        <!--brief start-->
                        <div class="p1">
                    <p id="39">目前, 经皮冠脉介入术 (PCI) 是治疗急性ST段抬高型心肌梗死 (STEMI) 常用手段之一, 其通过快速疏通梗死血管从而达到缓解临床症状的目的<citation id="69" type="reference"><link href="5" rel="bibliography" /><sup>[<a class="sup">1</a>]</sup></citation>。但也正是由于梗死血管的骤然通畅及血流流入, 反而对血管内皮造成损伤, 诱发血栓形成, 进而导致微血管栓塞及痉挛的发生<citation id="70" type="reference"><link href="7" rel="bibliography" /><sup>[<a class="sup">2</a>]</sup></citation>。因此, 具有抑制血小板聚集, 减少血栓形成的血小板糖蛋白 (GP) Ⅱb/Ⅲa受体可逆性拮抗剂―替罗非班在临床辅助治疗STEMI中获得广泛应用。而近年来研究发现PCI术后联合替罗非班对患者炎症反应以及心肌重构现象存在显著改善, 但其具体作用机制尚未明确<citation id="71" type="reference"><link href="9" rel="bibliography" /><sup>[<a class="sup">3</a>]</sup></citation>。于此同时, 新的STEMI标志物也不断被发现, 其中可溶性基质裂解素2 (Soluble stroma 2, sST2) 被证实与左心室射血分数存在负相关<citation id="72" type="reference"><link href="11" rel="bibliography" /><sup>[<a class="sup">4</a>]</sup></citation>;而正五聚体蛋白-3 (pentraxin-3, PTX-3) 则是炎症急性期反应蛋白, 且与心肌肌钙蛋白I呈现正相关性<citation id="73" type="reference"><link href="13" rel="bibliography" /><sup>[<a class="sup">5</a>]</sup></citation>。因此, 本研究探讨了PCI术联合替罗非班在STEMI中的应用效果, 并观察其对sST2以及PTX3表达水平的影响, 从而为进一步了解替罗非班的作用机理提供可参考依据。</p>
                </div>
                <h3 id="40" name="40" class="anchor-tag"><b>1 资料与方法</b></h3>
                <h4 class="anchor-tag" id="41" name="41">1.1 一般资料</h4>
                <div class="p1">
                    <p id="42">依据前瞻性研究, 将2014年2月～2017年3月在我院诊治, 且符合纳排标准的146例急性STEMI患者, 按照随机数字表纳入单纯PCI组 (PCI术) 和联合治疗组 (替罗非班+PCI术) , 每组73例。纳入标准: (1) 发病至实施PCI治疗时间&lt;12 h; (2) 符合《急性ST段抬高型心肌梗死诊断和治疗指南》中关于STEMI的诊断标准<citation id="74" type="reference"><link href="15" rel="bibliography" /><sup>[<a class="sup">6</a>]</sup></citation>; (3) 首次诊断为心肌梗死。排除标准: (1) 心肺复苏时间超过30min或患者持续处于昏迷状态: (2) PCI手术失败者: (3) 合并有肿瘤者: (4) 患者预计生存期&lt;1年者: (5) 合并有严重的肝肾功能障碍者: (6) 合并有高血压者。经统计, 单纯PCI组中男52例, 女21例;平均年龄 (43.2±13.2) 岁, 平均发病时间 (2.5±1.3) h;Killip心功能分级:Ⅰ级18例;Ⅱ级35例;Ⅲ级20 例;联合治疗组中男50例, 女23例;平均年龄 (43.8±12.9) 岁, 平均发病时间 (2.6±1.1) h;Killip心功能分级:Ⅰ级20例;Ⅱ级34例;Ⅲ级19 例。单纯PCI组与联合治疗组在性别构成、年龄、发病至就诊时间以及Killip分级差异均无统计学意义, 可纳入统计分析 (<i>P</i>&gt;0.05) 。本研究经我院伦理委员会批准, 患者知情并签署知情同意书。</p>
                </div>
                <h4 class="anchor-tag" id="43" name="43">1.2 治疗方法</h4>
                <div class="p1">
                    <p id="44">两组在经诊断及分组完毕后, 术前, 联合治疗组口服600mg氯吡格雷 (深圳信立泰药业股份有限公司 H20120018规格300mg) 、300mg阿司匹林 (辰欣药业股份有限公司 H20113013规格 100mg) , 随后静脉注射3000IU肝素 (杭州九源基因工程有限公司H19990035规格0.3ml/3000IU) 进行冠脉造影。并从股动脉或者桡动脉穿刺, 置入动脉鞘管到梗死动脉处, 导丝在到达病变处后, 通过Export导管抽吸血栓多次, 完毕后通过静脉推注方式给予10μg/kg 替罗非班 (鲁南贝特制药有限公司 H20173030, 规格 100ml:5mg) , 随后按照0.15μg·kg<sup>-1</sup>·min<sup>-1</sup>) 持续静脉滴注替罗非班, 直至术后36～48h。同时根据残余冠脉狭窄程度选择合适的球囊扩张并置入支架, 随后依次进行止血及包扎。术后联合治疗组患者口服75mg氯吡格雷 (深圳信立泰药业股份有限公司H20120035规格75mg) 及100mg 阿司匹林, 1次/d, 持续7d。单纯PCI组除未给予替罗非班辅助治疗外, 其余手术方法及药物治疗均同联合治疗组。</p>
                </div>
                <h4 class="anchor-tag" id="45" name="45">1.3 评估标准</h4>
                <div class="p1">
                    <p id="46">①再灌注指标:按心肌梗死溶栓 (TIMI) 血流分级标准, 采用冠脉造影技术评价PCI术前及术后1 个月患者冠状动脉再灌注情况。其中0级指血管闭塞且远端未见前向血流;1级指部分造影剂通过闭塞处, 但未能充盈冠脉远端血管;2级指造影剂全部充盈冠脉远端血管, 但充盈速度及清除速度慢于正常冠脉;3级指造影剂完全且迅速充盈冠脉远端血管<citation id="75" type="reference"><link href="17" rel="bibliography" /><sup>[<a class="sup">7</a>]</sup></citation>;②心脏功能:分别在PCI术前及术后6个月, 通过超声心动图对比两组患者左室射血分数 (LVEF) 以及左室舒张末期内径 (LVEDd) ;③血清学指标 两组患者分别在PCI术前及术后1个月空腹抽取5ml静脉血, 静置30min, 离心取上清。采用酶联免疫技术, 检测血清中sST2及PTX3水平。所用试剂盒均购自上海酶联生物科技有限公司;④两组主要心血管不良事件 (MACE) 发生率比较 记录两组患者术后住院期间以及术后随访6个月内发生心力衰竭、顽固性心绞痛、心肌梗死、心源性死亡以及靶向血管血运重建等事件。</p>
                </div>
                <h4 class="anchor-tag" id="47" name="47">1.4 统计学方法</h4>
                <div class="p1">
                    <p id="48">采用SPSS 25.0版对数据进行统计分析。计量资料以均数±标准差 (<image id="85" type="formula" href="images/XXGK201904023_08500.jpg" display="inline" placement="inline"><alt></alt></image>±s) 表示, 比较采用<i>t</i>检验, 计数资料以百分率表示, 比较采用秩和检验或<i>χ</i><sup>2</sup>检验。<i>P</i>&lt;0.05为差异有统计学意义。</p>
                </div>
                <h3 id="50" name="50" class="anchor-tag"><b>2 结 果</b></h3>
                <h4 class="anchor-tag" id="51" name="51">2.1 两组TIMI血流分级比较</h4>
                <div class="p1">
                    <p id="52">结果显示, PCI术前, 联合治疗组86.3% (63/73) 、单纯PCI组82.2% (60/73) TIMI&lt;3级, 组间比较无显著差异 (<i>P</i>&gt;0.05) ;PCI术后, 联合治疗组13.7% (10/73) 、单纯PCI组34.2% (25/73) TIMI&lt;3级, 组间差异存在统计学意义 (<i>P</i>&lt;0.05) , 见表1。</p>
                </div>
                <div class="area_img" id="53">
                                            <p class="img_tit">
                                                <b>表</b>1 <b>两组</b>PCI<b>前后</b>TIMI<b>血流分级</b> (n=73) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904023_05300.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904023_05300.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904023_05300.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表1 两组PCI前后TIMI血流分级 (n=73)" src="Detail/GetImg?filename=images/XXGK201904023_05300.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:PCI:经皮冠脉介入术, TIMI:心肌梗死溶栓。</p>

                </div>
                <h4 class="anchor-tag" id="54" name="54">2.2 两组LVEF及LVEDd比较</h4>
                <div class="p1">
                    <p id="55">由超声心动图结果显示, 术前两组患者LVEF及LVEDd均无显著差异 (<i>P</i>&gt;0.05) , 术后联合治疗组LVEF较单纯PCI组显著升高, LVEDd显著下降 (<i>P</i>均=0.001) , 见表2。</p>
                </div>
                <h4 class="anchor-tag" id="56" name="56">2.3 两组sST2及PTX3水平比较</h4>
                <div class="p1">
                    <p id="57">在PCI术前, 联合治疗组与单纯PCI组在sST2及PTX3表达水平无显著差异 (<i>P</i>&gt;0.05) 但在术后1个月复查时, 联合治疗组的上述两指标表达均较单纯PCI组显著下降 (<i>P</i>均=0.001) , 见表3。</p>
                </div>
                <h4 class="anchor-tag" id="58" name="58">2.4 两组MACE发生率比较</h4>
                <div class="p1">
                    <p id="59">结果显示, 联合治疗组MACE总发生率2.7% (2/73) 少于单纯PCI组24.7% (18/73) , 差异具有统计学意义 (<i>P</i>&lt;0.05) , 见表4。</p>
                </div>
                <div class="area_img" id="60">
                                            <p class="img_tit">
                                                表2 各组LVEF及LVEDd比较（<image id="86" type="formula" href="images/XXGK201904023_08600.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=73) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904023_06000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904023_06000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904023_06000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表2 各组LVEF及LVEDd比较（&#177;s，n=73)" src="Detail/GetImg?filename=images/XXGK201904023_06000.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:LVEF:左室射血分数, LVEDd:左室舒张末期内径。与治疗前比较*<i>P</i>&lt;0.05, **<i>P</i>&lt;0.01;与单纯PCI组比较△<i>P</i>&lt;0.05, △△<i>P</i>&lt;0.01。下表同。</p>

                </div>
                <div class="area_img" id="62">
                                            <p class="img_tit">
                                                表3 两组sST2及PTX3表达水平比较（<image id="87" type="formula" href="images/XXGK201904023_08700.jpg" display="inline" placement="inline"><alt></alt></image>±s，n=73) 
                                                
                                                &nbsp;&nbsp;
                                                <a class="btn-zoomin" href="Detail/GetImg?filename=images/XXGK201904023_06200.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!"></a>
                                                <a class="table downimg" data-tablename="Detail/GetImg?filename=images/XXGK201904023_06200.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">下载原表</a>
                                            </p>
                                    <a class="zoom-in" href="Detail/GetImg?filename=images/XXGK201904023_06200.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">
                                        <img alt="表3 两组sST2及PTX3表达水平比较（&#177;s，n=73)" src="Detail/GetImg?filename=images/XXGK201904023_06200.jpg&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
                                    </a>
                                <p class="img_note">注:sST2:可溶性基质裂解素2, PTX-3:正五聚体蛋白-3。</p>

                </div>
                <div class="area_img" id="64">
                    <p class="img_tit"><b>表</b>4 <b>两组患者主要心血管不良事件发生率比较</b> (n=73)  <a class="downexcel" onclick="DownLoadReportExcel(this)">导出到EXCEL</a></p>
                    <p class="img_tit"></p>
                    <p class="img_note"></p>
                    <table id="64" border="1"><tr><td><br />组别</td><td>心力衰竭<br /><i>n</i> (%) </td><td>顽固性心绞痛<br /><i>n</i> (%) </td><td>心肌梗死<br /><i>n</i> (%) </td><td>心源性死亡<br /><i>n</i> (%) </td><td>靶向血管血运重建<br /><i>n</i> (%) </td><td>总发生率<br /><i>n</i> (%) </td></tr><tr><td><br />联合治疗组</td><td>1 (1.4) </td><td>1 (1.4) </td><td>0 (0) </td><td>0 (0) </td><td>0 (0) </td><td>2 (2.7) <sup>△△</sup></td></tr><tr><td><br />单纯PCI组</td><td>7 (9.6) </td><td>4 (5.5) </td><td>3 (4.1) </td><td>2 (2.7) </td><td>2 (2.7) </td><td>18 (24.7) </td></tr><tr><td><br /><i>χ</i><sup>2</sup></td><td>3.306</td><td>0.828</td><td>1.361</td><td>0.507</td><td>0.507</td><td>14.832</td></tr><tr><td><br /><i>P</i></td><td>0.069</td><td>0.363</td><td>0.243</td><td>0.476</td><td>0.476</td><td>0.001</td></tr></table>
                    <form name="form" action="/kxreader/Detail/DownloadReportExcel" method="POST" style="display:inline">
                        <input type="hidden" name="hidTable" value="" />
                        <input type="hidden" name="hidFileName" value="" />
                    </form>
                    <p class="img_note"></p>
                    <p class="img_note"></p>
                </div>
                <h3 id="65" name="65" class="anchor-tag"><b>3 讨 论</b></h3>
                <div class="p1">
                    <p id="66">临床研究发现, STEMI的发生与冠状动脉破裂及血栓形成存在直接相关性, 且血小板的活化、黏附及聚集更是整个病程的发生及发展的关键所在<citation id="76" type="reference"><link href="19" rel="bibliography" /><sup>[<a class="sup">8</a>]</sup></citation>。然而, PCI虽然可以快速缓解STEMI临床症状, 但无法抑制血小板的生物学功能及血栓的形成。因而, 单纯使用PCI术后1个月MACE往往发生率高达30%左右, 大大影响了PCI对于STEMI的临床治疗效果<citation id="77" type="reference"><link href="21" rel="bibliography" /><sup>[<a class="sup">9</a>]</sup></citation>。因此, 在临床PCI术应用中, 多建议联合抗血栓药物, 而替罗非班即是临床应用较为广泛的一种抗血栓药物。以往研究显示, 替罗非班主要通过抑制GPⅡb/Ⅲa受体与纤维蛋白原的结合发挥抗血小板聚集及抗血栓作用<citation id="78" type="reference"><link href="23" rel="bibliography" /><sup>[<a class="sup">10</a>]</sup></citation>。正如陈晖<citation id="79" type="reference"><link href="25" rel="bibliography" /><sup>[<a class="sup">11</a>]</sup></citation>等人通过比较单纯PCI术及PCI术联合替罗非班在STEMI临床效果可知, 联合替罗非班可减少MACE发生率, 并改善心肌灌注水平。而本研究采用陈晖的相同的分组依据, 并通过TIMI血流分级标准、LVEF及LVEDd以及MACE发生率进一步验证替罗非班的临床效果。其结果基本前人的研究结论一致<citation id="80" type="reference"><link href="25" rel="bibliography" /><link href="27" rel="bibliography" /><sup>[<a class="sup">11</a>,<a class="sup">12</a>]</sup></citation>, 本文中治疗后联合治疗组13.7% (10/73) TIMI&lt;3级, 而单纯PCI组34.2% (25/73) TIMI&lt;3级, 组间差异具有统计学意义 (<i>P</i>&lt;0.05) , 同时联合治疗组LVEF及LVEDd指标改善情况优于单纯PCI组, 且在随访6个月后, 联合治疗组共2.7% (2/73) 发生MACE, 少于单纯PCI组24.7% (18/73) , 差异具有统计学意义 (<i>P</i>&lt;0.05) 。而这可能得益于替罗非班能有效抑制微小血栓的形成, 从而避免了微血管栓塞的发生。可见, 替罗非班联合PCI在STEMI中确有一定的临床应用价值。</p>
                </div>
                <div class="p1">
                    <p id="67">另外, 随着大量生物标志物的发现以及对STEMI发病机制的深入了解, 人们发现 PTX-3以及ST2表达水平与STEMI PCI术后转归具有显著的相关性<citation id="81" type="reference"><link href="29" rel="bibliography" /><sup>[<a class="sup">13</a>]</sup></citation>。何蕾<citation id="82" type="reference"><link href="31" rel="bibliography" /><sup>[<a class="sup">14</a>]</sup></citation>等依据sST2表达水平将121例STEMI患者分为高表达组及低表达组, 其发现sST2低表达组MACE发生率仅为8.2%, 远低于sST2高表达组的30%, 且通过多因素Cox回归分析亦进一步证实sST2是STEMI患者发生MACE及死亡的独立危险因素。此外, 血管及心脏损伤时又可大量释放急性期炎症蛋白PTX3, 且有文献证实PTX3与心肌肌钙蛋白I存在正相关性, 而后者是目前用于评估心肌损伤的重要指标<citation id="83" type="reference"><link href="33" rel="bibliography" /><sup>[<a class="sup">15</a>]</sup></citation>。而在本研究中发现, 给予替罗非班的联合治疗组术后sST2及PTX3表达水平下降幅度均高于单纯PCI组。由于sST2以及PTX3均受心肌梗死面积、左心室形态以及心肌机械力多因素影响的综合性指标, 而替罗非班可以通过抑制血小板聚集及交联, 并抑制缩血管物质及炎症因子的释放, 改善PCI术后血管收缩过度, 改善术后心脏血液供应, 从而对血管内皮功能及心脏起到一定的保护作用, 从而影响了sST2及PTX3指标的表达, 但是替罗非班是直接作用还是间接影响sST2及PTX3表达则有待进一步研究<citation id="84" type="reference"><link href="35" rel="bibliography" /><link href="37" rel="bibliography" /><sup>[<a class="sup">16</a>,<a class="sup">17</a>]</sup></citation>。</p>
                </div>
                <div class="p1">
                    <p id="68">综上所述, 对于STEMI患者, 实施替罗非班辅助PCI术有助于改善心脏灌注水平以及心脏功能, 减少术后MACE发生率, 并影响sST2及PTX3表达水平, 从而对STEMI的远期疗效起到积极作用。但是鉴于本次纳入病例数有限, 且未对患者进行更为长期的随访研究, 因而, 将在后续研究中, 将针对上述问题进行大样本, 长随访的前瞻性研究, 以便获得更为可靠的结论。</p>
                </div>

        <!--brief end-->
        
        <!--conten left  end-->
        <!--增强附件-->
        

        <!--reference start-->
            <div class="reference anchor-tag" id="a_bibliography">
                    <h3>参考文献</h3>
                                        <p id="5">
                            <a id="bibliography_1" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJES14121200074416&amp;v=MzAyODIwL29CTVQ2VDRQUUgvaXJSZEdlcnFRVE1ud1plWnRGaW5sVXJmSUlGd1RheGM9TmlmT2ZiSzhIOVBOclk5RlpPd0xDSA==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[1]</b>Boukhris M, Bousselmi R, Tomasello S D, et al.Mechanical post-conditioning in STEMI patients undergoing primary percutaneous coronary intervention.[J].J Saudi Heart Assoc, 2015, 27 (3) :192-200.
                            </a>
                        </p>
                        <p id="7">
                            <a id="bibliography_2" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJES&amp;filename=SJESB7182A561FFEBC0C886271E837502DEA&amp;v=MTg2NzQwPU5pZk9mY0cvSDluTzNvcERaWjE1ZVE1S3oyVWI0amwvVDM2WHBCRXlmTEtXTWMvdUNPTnZGU2lXV3I3SklGcG1hQnVIWWZPR1FsZkJyTFUwNXRCaHhMcTR3YQ==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[2]</b>Dastidar AG, Rodrigucs J, Baritussio A, et al.Reply:Complete ReVascization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI:Is It Really What We Should Be Doing?[J].Journal of the American College of Cardiology, 2015, 66 (3) :331-332.
                            </a>
                        </p>
                        <p id="9">
                            <a id="bibliography_3" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Safety and efficacy of early application of tirofiban in STEMI patients undergoing primary percutaneous coronary intervention">

                                <b>[3]</b> Fu X, Wang Z, Wang Y, et al.Safety and efficacy of early application of tirofiban in STEMI patients undergoing primary percutaneous coronary intervention[J].Heart, 2011, 97 (Suppl 3) :A153-A153.
                            </a>
                        </p>
                        <p id="11">
                            <a id="bibliography_4" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=QKYX201627028&amp;v=MDAxMTFtRnlqblZMN05OQ2JTZHJHNEg5Zk9xSTlIYklRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVo=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[4]</b>胡振, 张新超.可溶性人基质裂解素2在评估心力衰竭病情和预后中的作用[J].中国全科医学, 2016, 19 (27) :3375-3379.
                            </a>
                        </p>
                        <p id="13">
                            <a id="bibliography_5" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=SYYZ201622022&amp;v=MzA0NzZWTDdOTmpUU2RMRzRIOWZPclk5SFpvUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am4=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[5]</b>侯维娜, 金凤表, 孙宏超, 等.血清Syndecan-4、PTX-3、BNP水平检测在诊断慢性心力衰竭的临床价值[J].实用医学杂志, 2016, 32 (22) :3709-3712.
                            </a>
                        </p>
                        <p id="15">
                            <a id="bibliography_6" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZHXX201505003&amp;v=MzExNDZHNEg5VE1xbzlGWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN05QeVhUZHI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[6]</b>中华医学会心血管病学分会, 中华心血管病杂志编辑委员会.急性ST段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2015, 43 (5) :380-393.
                            </a>
                        </p>
                        <p id="17">
                            <a id="bibliography_7" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=PZXX201601014&amp;v=MTc3NTlOTlRmVGRyRzRIOWZNcm85RVlJUUtESDg0dlI0VDZqNTRPM3pxcUJ0R0ZyQ1VSN3FmWnVabUZ5am5WTDc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[7]</b>程云涛, 杨光霞, 李传方, 等.替罗非班联合大剂量阿托伐他汀对急诊PCI术中冠状动脉血流恢复的影响[J].中国循证心血管医学杂志, 2016, 8 (1) :43-45, 53.
                            </a>
                        </p>
                        <p id="19">
                            <a id="bibliography_8" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Protective effects of tirofiban hydrochloride,a glycoprotein IIb/IIIa inhibitor,on liver ischemia/reperfusion injury in rats">

                                <b>[8]</b>Paltaci I, Aydogan A, Akkucuk S, et al.Protective effects of tirofiban hydrochloride, a glycoprotein IIb/IIIa inhibitor, on liver ischemia/reperfusion injury in rats[J].Acta Medica Mediterranea, 2015, 31 (1) :121-126.
                            </a>
                        </p>
                        <p id="21">
                            <a id="bibliography_9" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI">

                                <b>[9]</b>Türker Y.Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :956.
                            </a>
                        </p>
                        <p id="23">
                            <a id="bibliography_10" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SSJD&amp;filename=SSJD15011600011155&amp;v=MDQ3OThkR2VycVFUTW53WmVadEZpbmxVcmZJSUZ3VGF4Yz1OajdCYXJLOUh0RE5xWTlGWk9vT0RYazhvQk1UNlQ0UFFIL2lyUg==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[10]</b>Wang K, Zuo G, Zheng L, et al.Effects of Tirofiban on Platelet Activation and Endothelial Function in Patients with ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention[J].Cell BioChem Biophy, 2015, 71 (1) :135-142.
                            </a>
                        </p>
                        <p id="25">
                            <a id="bibliography_11" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=MEDI201502043&amp;v=MjI0MjhadVptRnlqblZMN05LQ2pQWjdHNEg5VE1yWTlCWjRRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWY=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[11]</b>陈晖, 余淑华, 刘毓.替罗非班在急性ST段抬高型心肌梗死直接PCI术中的应用[J].中国实用医刊, 2015, 42 (2) :91-92.
                            </a>
                        </p>
                        <p id="27">
                            <a id="bibliography_12" target="_blank" href="http://scholar.cnki.net/result.aspx?q=The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI">

                                <b>[12]</b>Kaymaz C, Keles N, Õzdemir N, et al.The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI[J].Anatol J Cardiol, 2015, 15 (11) :899-906.
                            </a>
                        </p>
                        <p id="29">
                            <a id="bibliography_13" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=LCXB201604021&amp;v=MDE3MzJGeWpuVkw3TktTN1RiTEc0SDlmTXE0OUhaWVFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm0=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[13]</b>李宇球, 林玲, 王蓓.射血分数保留的心力衰竭生物标志物的研究进展[J].临床心血管病杂志, 2016, 32 (4) :403-408.
                            </a>
                        </p>
                        <p id="31">
                            <a id="bibliography_14" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZGXH201701011&amp;v=MTI3ODZHNEg5Yk1ybzlFWllRS0RIODR2UjRUNmo1NE8zenFxQnRHRnJDVVI3cWZadVptRnlqblZMN05QeXJUWnI=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[14]</b>何蕾, 彭剑, 郑璇, 等.血清可溶性致癌抑制因子2水平与急性ST段抬高型心肌梗死患者近期临床预后的相关性研究[J].中国循环杂志, 2017, 32 (1) :41-45.
                            </a>
                        </p>
                        <p id="33">
                            <a id="bibliography_15" target="_blank" href="/kcms/detail/detail.aspx?dbcode=SJSD&amp;filename=SJSD6EF108C501D94B8E2AA29267D8DEDC5C&amp;v=MTI0NTZxMlk5RGNmZ05yL3NDT052RlNpV1dyN0pJRnBtYUJ1SFlmT0dRbGZCckxVMDV0Qmh4THE0d2EwPU5pZllhclhOYU5ETXAveEFaT3A3QlhoTHgyTVJtMDUvUVgzaw==&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[15]</b>Yuan X, Xiang Y, Zhu N, et al.Salvianolic acid A protects against myocardial ischemia/reperfusion injury by reducing platelet activation and inflammation[J].Exp Ther Med, 2017, 14 (2) :961-966.
                            </a>
                        </p>
                        <p id="35">
                            <a id="bibliography_16" target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=ZJXB201604007&amp;v=MzAwMDF5ZlRiTEc0SDlmTXE0OUZZNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3TlA=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">

                                <b>[16]</b>王江友, 陈涵, 苏晞, 等.可溶性生长刺激表达因子-2对不同类型冠心病患者远期预后的影响[J].中国介入心脏病学杂志, 2016, 24 (4) :195-199.
                            </a>
                        </p>
                        <p id="37">
                            <a id="bibliography_17" target="_blank" href="http://scholar.cnki.net/result.aspx?q=Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio">

                                <b>[17]</b>Yaman M, Arslan U, Beton O, et al.Early and late aortic propagation velocity values in STEMI patients after successful primary PCI and their relationship with neutrophil to lymphocyte ratio[J].Eur Rev Med Pharmacol Sci, 2016, 20 (5) :912-918.
                            </a>
                        </p>
            </div>
        <!--reference end-->
        <!--footnote start-->
        <!--footnote end-->



    </div>

        <input id="fileid" type="hidden" value="XXGK201904023" />
        <input id="dpi" type="hidden" value="300" />
    </div>

<script>
var _hmt = _hmt || [];
(function() {
  var hm = document.createElement("script");
  hm.src = "https://hm.baidu.com/hm.js?6e967eb120601ea41b9d312166416aa6";
  var s = document.getElementsByTagName("script")[0];
  s.parentNode.insertBefore(hm, s);
})();
</script>

    


<input id="hid_uid" name="hid_uid" type="hidden" value="WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!" />
<input id="hid_kLogin_headerUrl" name="hid_kLogin_headerUrl" type="hidden" value="/KLogin/Request/GetKHeader.ashx%3Fcallback%3D%3F" />
<input id="hid_kLogin_footerUrl" name="hid_kLogin_footerUrl" type="hidden" value="/KLogin/Request/GetKFooter.ashx%3Fcallback%3D%3F" />
<div class="btn-link" style="display: none"><a target="_blank" href="/kcms/detail/detail.aspx?dbcode=CJFD&amp;filename=XXGK201904023&amp;v=MDA3Mjc0SDlqTXE0OUhaNFFLREg4NHZSNFQ2ajU0TzN6cXFCdEdGckNVUjdxZlp1Wm1GeWpuVkw3S1BUWE1aYkc=&amp;uid=WEEvREcwSlJHSldRa1FhdXNzY2Z1OVRrR0lUaXl3ejFCL1duS1pTRmd1dz0=$9A4hF_YAuvQ5obgVAqNKPCYcEjKensW4IQMovwHtwkF4VYPoHbKxJw!!">知网节</a></div>
<div class="popflow" id="popupTips" style="display: none;">
    <div class="popflowArr"></div>
    <div class="popflowCot">
        <div class="hd"><a href="javascript:void(0);" onclick="$('#popupTips').hide();$('#popupmsg').html('')" class="close">X</a></div>
        <div class="bd">
            <p class="mes" id="popupmsg" name="popupmsg"></p>
          
        </div>
    </div>
</div>
<input type="hidden" id="myexport" value="//kns.cnki.net" />

<input type="hidden" id="KPCAPIPATH" value="//ishufang.cnki.net" />
<input type="hidden" id="CitedTimes" value="" />
<div class="link" id="GLSearch" style="display: none;">
    <i class="icon-trangle"></i>
    <div class="inner">
        <a class="icon" id="copytext">复制</a>
        <a class="icon" target="_blank" onclick="searchCRFD(this)">工具书搜索</a>
    </div>
</div>




<input id="hidVirtualPath" name="hidVirtualPath" type="hidden" value="/kxreader" />
<script src="/kxreader/bundles/detail?v=842_VlRz_g1CMCLi-M0twVw-4EOFG_noWyi_OsMnrAg1"></script>

<script src="/kxreader/Scripts/layer.min.js" type="text/javascript"></script>

<div id="footerBox" class="rootw footer">
</div>
<script>
    if (typeof FlushLogin == 'function') {
        FlushLogin();
    }
    modifyEcpHeader(true);
</script>

<!--图片放大功能 start-->
<script src="/kxreader/bundles/imagebox?v=W4phPu9SNkGcuPeJclikuVE3PpRyIW_gnfjm_19nynI1"></script>

<script type="text/javascript">
    $(function () {
        var j = $.noConflict();
        j(function () {
            j(".zoom-in,.btn-zoomin").imgbox({
                'alignment': 'center',
                'allowMultiple': false,
                'overlayShow': true
            });
        })
    });
</script>
<!--图片放大功能 end-->
<div class="fixedbar">
    <div class="backtop hiddenV" id="backtop">
        <a id="backTopSide" href="javascript:scroll(0,0);" title=""></a>
    </div>
</div>
<script type="text/javascript" src="/kxreader/Scripts/MathJax-2.6-latest/MathJax.js?config=MML_HTMLorMML-full"></script>

</body>
</html>
